1262132-93-3

Basic information

• Product Name: tert-butyl 4-(benzyloxy)-2-chloronicotinate
• Synonyms: tert-butyl 4-(benzyloxy)-2-chloronicotinate
• CAS NO: 1262132-93-3
• Molecular Weight: 319.788
• Mol File: 1262132-93-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(benzyloxy)-2-chloronicotinate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(benzyloxy)-2-chloronicotinate(1262132-93-3)
• EPA Substance Registry System: tert-butyl 4-(benzyloxy)-2-chloronicotinate(1262132-93-3)

Safety Data

• Hazardous Substances Data: 1262132-93-3(Hazardous Substances Data)

Upstream product

• 26452-80-2 2,4-dichloropyridine 
• 262423-77-8 2,4-dichloronicotinic acid 
• 1262132-92-2 tert-butyl 2,4-dichloronicotinate 
• 100-51-6 benzyl alcohol 

Downstream Products

• 1262132-94-4 tert-butyl 4-(benzyloxy)-2-hydrazinylnicotinate 
• 1262132-85-3 {[5-(4-fluoro-3-trifluoromethylphenyl)-7-hydroxy[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]amino}acetic acid 
• 1262132-95-5 tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate 
• 1262132-97-7 tert-butyl 7-(benzyloxy)-5-iodo-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262132-98-8 C₂₅H₂₁F₄N₃O₃ 
• 1262132-99-9 C₂₁H₁₃F₄N₃O₃ 
• 1262133-00-5 C₂₅H₂₀F₄N₄O₄ 
• 1262133-01-6 C₁₈H₁₄F₄N₄O₄ 
• 1262133-02-7 tert-butyl 7-(benzyloxy)-5-(phenylethynyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262133-03-8 C₂₂H₁₅N₃O₃ 
• 1262133-07-2 tert-butyl 7-(benzyloxy)-5-butyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262132-96-6 tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262132-05-7 (5-(3-chlorophenyl)-7-hydroxy-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycine 
• 1262133-44-7 tert-butyl (7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carbonyl)glycinate 

Relevant articles and documents

Fused ring heteroaryl derivative as well as pharmaceutical composition and treatment method and application thereof

The present invention relates to a fused ring heteroaryl derivative represented by formula (I) or a tautomer thereof. Use HIF of an optical isomer, an oxynitride, a solvate, or a pharmaceutically acceptable salt or prodrug thereof, for the treatment or al

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents.